EP3672594
COMBINATION PRODUCT OF BCL-2 INHIBITOR AND MDM2 INHIBITOR AND USE THEREOF IN THE PREVENTION AND/OR TREATMENT OF DISEASES
:
EP einkaleyfi: Þýðing ekki lögð inn:
22.7.2019:
29.9.2021:
19844990.2
:
21.7.2039
:
COMBINATION PRODUCT OF BCL-2 INHIBITOR AND MDM2 INHIBITOR AND USE THEREOF IN THE PREVENTION AND/OR TREATMENT OF DISEASES
22.7.2019
29.9.2021
:
Ascentage Pharma (Suzhou) Co., Ltd.:
Unit 701, Building B7, 218 Xinghu Street Suzhou Industrial Park, Suzhou, Jiangsu 215000, CN
:
YANG, Dajun:
Suzhou, Jiangsu 215000, CN
:
ZHAI, Yifan:
Suzhou, Jiangsu 215000, CN
:
TANG, Qiuqiong:
Suzhou, Jiangsu 215000, CN
:
FANG, Douglas Dong:
Suzhou, Jiangsu 215000, CN
:
201810862170:
31.7.2018:
CN
:
CN2019096968:
22.7.2019
:
A61K 31/496, A61K 31/407, A61P 35/00, A61P 35/02